CONFERENCE REPORT

ASCO 2011: Dr. Joseph Connors Discusses Novel Treatments and New Research on Hodgkin Lymphoma

Interviewed by the editors of Oncology | June 9, 2011

In this video CancerNetwork interviews Dr. Joseph Connors, clinical director at the Centre for Lymphoid Cancer, BC Cancer Agency, and Clinical Professor, University of British Columbia, Vancouver.

Dr. Connors gives an overview of the results presented here at ASCO of the phase II trial of brentuximab vedotin in patients with relapsed or refractory Hodgkin lymphoma, and discusses the most intriguing work currently being done with novel agents used to treat relapsed or refractory Hodgkin lymphoma.

ASCO 2011: HEMATOLOGY

ASCO 2011: Dr. Joseph Connors Discusses Novel Treatments and New Research on Hodgkin Lymphoma
June 9, 2011

ASCO 2011: Better Knowledge, Better Treatments in Myelodysplatic Syndromes
June 8, 2011

ASCO 2011: High-Dose Methotrexate May Benefit Young ALL Patients
June 6, 2011

ASCO 2011: Anderson, in Karnofsky Lecture, Discusses His Multiple Myeloma Research – and How It Has Benefited Patients
June 5, 2011

ASCO 2011: Susan O'Brien Discusses New Developments in Chronic Lymphocytic Leukemia and Gives a Preview of Upcoming ASCO Session
June 2, 2011

TOPIC INDEX

Cancer Types
Breast Breast (HER2+) Breast (Triple-Negative) CML Colorectal Gastrointestinal GIST Genitourinary Gynecologic Head & Neck	Hematology Kidney (Renal Cell) Leukemia Lung Lymphoma Melanoma Multiple Myeloma Ovarian Prostate Sarcoma
Supportive Care	More Topics
Bone Metastases End-of-Life Care Palliative Care	Ethics in Oncology Practice Management Practice & Policy

MOST POPULAR

Click here to subscribe to our newsletter